Different structures of the two peroxisome proliferator-activated receptor gamma (PPARγ) ligand-binding domains in homodimeric complex with partial agonist, but not full agonist
- 1 July 2015
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (13) , 2639-2644
Abstract
No abstract availableKeywords
Funding Information
- KAKENHI (26293027)
- MEXT
This publication has 14 references indexed in Scilit:
- Structural design and synthesis of arylalkynyl amide-type peroxisome proliferator-activated receptor γ (PPARγ)-selective antagonists based on the helix12-folding inhibition hypothesisEuropean Journal of Medicinal Chemistry, 2015
- Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivityBioorganic & Medicinal Chemistry, 2013
- Peroxisome Proliferator-Activated Receptors (PPARs) Have Multiple Binding Points That Accommodate Ligands in Various Conformations: Phenylpropanoic Acid-Type PPAR Ligands Bind to PPAR in Different Conformations, Depending on the SubtypeJournal of Medicinal Chemistry, 2012
- Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) ModulatorsJournal of Medicinal Chemistry, 2011
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesisNature Reviews Endocrinology, 2010
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- C/EBPα induces adipogenesis through PPARγ: a unified pathwayGenes & Development, 2002
- A Unified Nomenclature System for the Nuclear Receptor SuperfamilyCell, 1999
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 1996
- Model studies for the synthesis of quassinoids. 1. Construction of the BCE ring systemThe Journal of Organic Chemistry, 1980